Monopar Therapeutics [MNPR]

Source: 

Company Overview

Monopar Therapeutics is a clinical stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve quality of life for cancer patients. We are building a drug development pipeline through the licensing and acquisition of therapeutics in late preclinical and clinical development stages.